Stay updated on Pembrolizumab for HR+ Inflammatory Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for HR+ Inflammatory Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for HR+ Inflammatory Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page’s displayed software/document revision was updated from v3.5.2 to v3.5.3, indicating a minor backend or release update rather than a change to the clinical trial’s content.
    Difference
    0.1%
    Check dated 2026-04-24T06:32:29.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:45:40.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Added glossary term 'Inflammatory breast carcinoma' and a new Resources entry for Genetic and Rare Diseases Information Center. Updated the revision note from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-19T04:50:30.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed on the page, replacing v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:21:54.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Administrative site updates: a new revision entry (v3.4.2) and removal of an older funding notice; these changes do not affect the study details or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T14:21:42.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Added a government-funding notice banner indicating the NIH Clinical Center is open and where to check status updates (opm.gov). Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T10:28:48.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for HR+ Inflammatory Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for HR+ Inflammatory Breast Cancer Clinical Trial page.